Aurora Cannabis [ACB] vs Lifecore Biomedical [LFCR] Detailed Stock Comparison

Aurora Cannabis Inc.

NASDAQ
Loading...

Lifecore Biomedical Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Aurora Cannabis Inc. wins in 12 metrics, Lifecore Biomedical Inc. wins in 7 metrics, with 0 ties. Aurora Cannabis Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Aurora Cannabis Inc. Lifecore Biomedical Inc. Better
P/E Ratio (TTM) 20.75 56.23 Aurora Cannabis Inc.
Price-to-Book Ratio 0.49 -17.45 Aurora Cannabis Inc.
Debt-to-Equity Ratio 17.79 414.80 Aurora Cannabis Inc.
PEG Ratio -0.22 -1.24 Aurora Cannabis Inc.
EV/EBITDA -6.42 44.66 Lifecore Biomedical Inc.
Profit Margin (TTM) -22.51% -23.78% Aurora Cannabis Inc.
Operating Margin (TTM) 2.32% 8.18% Lifecore Biomedical Inc.
EBITDA Margin (TTM) 2.32% 8.18% Lifecore Biomedical Inc.
Return on Equity -15.51% 312.34% Lifecore Biomedical Inc.
Return on Assets (TTM) -4.36% -19.11% Aurora Cannabis Inc.
Free Cash Flow (TTM) $-2.85M $-13.62M Aurora Cannabis Inc.
1-Year Return -48.03% -16.20% Lifecore Biomedical Inc.
Price-to-Sales Ratio (TTM) 0.54 1.51 Aurora Cannabis Inc.
Enterprise Value $153.59M $368.08M Lifecore Biomedical Inc.
EV/Revenue Ratio 0.56 2.84 Aurora Cannabis Inc.
Gross Profit Margin (TTM) 49.50% 25.04% Aurora Cannabis Inc.
Revenue per Share (TTM) $7 $3 Aurora Cannabis Inc.
Earnings per Share (Diluted) $-1.09 $-1.27 Aurora Cannabis Inc.
Beta (Stock Volatility) 1.32 0.88 Lifecore Biomedical Inc.
Short % of Float N/A 12.08% N/A

Aurora Cannabis Inc. vs Lifecore Biomedical Inc. Stock Performance Analysis

Loading Price Chart...

ACB
LFCR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Aurora Cannabis Inc.1.94%-2.95%-8.04%-28.14%-36.47%-39.40%
Lifecore Biomedical Inc.-2.66%-1.44%24.77%25.63%-30.33%-29.07%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Aurora Cannabis Inc.-48.03%-43.70%-96.52%-93.07%-95.89%-95.89%
Lifecore Biomedical Inc.-16.20%-31.88%-50.83%-48.63%-4.73%-36.20%

Performance & Financial Health Analysis: Aurora Cannabis Inc. vs Lifecore Biomedical Inc.

MetricACBLFCR
Market Information
Market Cap i$200.44M$184.39M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i2,150,062368,972
90 Day Avg. Volume i1,122,591505,534
Last Close$2.63$5.49
52 Week Range$2.56 - $6.66$3.63 - $8.98
% from 52W High-60.54%-38.86%
All-Time High$1,503.00 (Oct 15, 2018)$20.75 (May 20, 1996)
% from All-Time High-99.83%-73.54%
Growth Metrics
Quarterly Revenue Growth0.07%-0.15%
Quarterly Earnings Growth-0.94%0.26%
Financial Health
Profit Margin (TTM) i-0.23%-0.24%
Operating Margin (TTM) i0.02%0.08%
Return on Equity (TTM) i-0.16%3.12%
Debt to Equity (MRQ) i17.79414.80
Cash & Liquidity
Book Value per Share (MRQ)$6.92$-0.38
Cash per Share (MRQ)$1.91$0.47
Operating Cash Flow (TTM) i$-7,019,844$12.57M
Levered Free Cash Flow (TTM) i$8.67M$163.59M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Aurora Cannabis Inc. vs Lifecore Biomedical Inc.

MetricACB (Apr 26, 2026)LFCR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i20.7556.23
Forward P/E i-30.82-6.30
PEG Ratio i-0.22-1.24
Price to Sales (TTM) i0.541.51
Price to Book (MRQ) i0.49-17.45
Market Capitalization
Market Capitalization i$200.44M$184.39M
Enterprise Value i$153.59M$368.08M
Enterprise Value Metrics
Enterprise to Revenue i0.562.84
Enterprise to EBITDA i-6.4244.66
Risk & Other Metrics
Beta i1.320.88
Book Value per Share (MRQ) i$6.92$-0.38

Financial Statements Comparison: Aurora Cannabis Inc. vs Lifecore Biomedical Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricACB (2025)LFCR (2025)
Revenue/Sales i343.29M128.87M
Cost of Goods Sold i155.69M88.57M
COGS % of Revenue i45.4%68.7%
Gross Profit i187.61M40.30M
Gross Margin i54.6%31.3%
Research & Development i3.68M8.26M
Operating Income (EBIT) i9.98M-12.01M
Operating Margin i2.9%-9.3%
EBITDA i44.79M-3.65M
EBITDA Margin i13.0%-2.8%
Pre-Tax Income i20.38M-38.67M
Pre-Tax Income % of Revenue i5.9%-30.0%
Income Tax i4.62M43,000
Income Tax % of Revenue i1.3%0.0%
Net Income (Profit) i1.59M-38.72M
Profit Margin i0.5%-30.0%

Balance Sheet & Liquidity Metrics

MetricACB (2025)LFCR (2025)
Cash & Equivalents i137.92M17.47M
Total Current Assets i478.33M82.29M
Total Current Assets % of Revenue i139.3%63.9%
Total Current Liabilities i110.86M23.57M
Total Current Liabilities % of Revenue i32.3%18.3%
Long-Term Debt i77.69M141.28M
Long-Term Debt % of Revenue i22.6%109.6%
Total Shareholders Equity i608.59M-14.20M
Retained Earnings i-6.37B-223.20M
Retained Earnings % of Revenue i-1,854.9%-173.2%
Property, Plant & Equipment i157.87M0

Cash Flow Statement Comparison

MetricACB (2025)LFCR (2025)
Operating Cash Flow i24.19M-1.65M
Operating Cash Flow % of Revenue i7.0%-1.3%
Capital Expenditures i-16.83M-6.42M
Free Cash Flow i-2.85M-13.62M
FCF Margin i-0.8%-10.6%
Debt Repayment i-12.49M-145.76M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricACBLFCR
Shares Short i7.30M2.59M
Short Ratio i12.395.49
Short % of Float iN/A12.08%
Shares Outstanding i56.71M37.47M
Float Shares i56.43M19.84M
% Held by Insiders i0.00%1.92%
% Held by Institutions i12.96%76.45%
% Held by Public i87.04%21.63%

Dividend Analysis & Yield Comparison: Aurora Cannabis Inc. vs Lifecore Biomedical Inc.

MetricACBLFCR
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A